PHAGE 500 TABLET

Description

PHAGE 500 TABLET is a potent macrolide antibiotic formulation containing Azithromycin 500 mg, designed for the treatment of various bacterial infections affecting the respiratory tract, skin, ears, and genitals. Known for its high tissue penetration and long half-life, Azithromycin offers a convenient once-daily dosage regimen, improving patient compliance and treatment outcomes.

PHAGE 500 TABLET is commonly prescribed for:

Upper and lower respiratory tract infections (e.g., sinusitis, bronchitis, pneumonia)
Throat and ear infections (e.g., pharyngitis, otitis media)
Skin and soft tissue infections
Sexually transmitted infections (e.g., chlamydia)
Certain gastrointestinal infections caused by susceptible organisms

Azithromycin works by inhibiting bacterial protein synthesis, thereby stopping bacterial growth and allowing the immune system to clear the infection. Unlike many traditional antibiotics, it accumulates in infected tissues and releases slowly, making shorter treatment courses effective.

Contains 500 mg Azithromycin per tablet
Once-daily dosing for 3–5 days depending on the condition
Highly effective against both Gram-positive and Gram-negative bacteria
Well-tolerated with a favorable safety profile
Minimal drug resistance when used appropriately

PHAGE 500 TABLET is manufactured under stringent international quality protocols in WHO-GMP, ISO, and FDA-certified facilities. It undergoes rigorous quality control processes to ensure purity, potency, and stability throughout its shelf life.

BLUEPILL EXPRESS, the global representative and exporter of PHAGE 500 TABLET, ensures worldwide availability through a reliable and regulatory-compliant supply chain. The company has a strong presence across North America, Europe, Asia, Africa, Latin America, and the Middle East, delivering consistent pharmaceutical quality and international documentation support.